Comparative analysis of pulmonary function decline in patients undergoing bronchoscopic lung volume reduction with endobronchial valves versus conservative treatment in emphysema management: A longitudinal coarsened exact matched analysis.
Johannes Wienker, Kaid Darwiche, Rüdiger Karpf-Wissel, Dirk Westhölter, Erik Büscher, Sebastian Zensen, Johannes Haubold, David Kersting, Hubertus Hautzel, Josef Homola, Christian Taube, Marcel Opitz, Marc Struß
{"title":"Comparative analysis of pulmonary function decline in patients undergoing bronchoscopic lung volume reduction with endobronchial valves versus conservative treatment in emphysema management: A longitudinal coarsened exact matched analysis.","authors":"Johannes Wienker, Kaid Darwiche, Rüdiger Karpf-Wissel, Dirk Westhölter, Erik Büscher, Sebastian Zensen, Johannes Haubold, David Kersting, Hubertus Hautzel, Josef Homola, Christian Taube, Marcel Opitz, Marc Struß","doi":"10.1177/14799731251350709","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundChronic obstructive pulmonary disease (COPD) and emphysema display a chronic and progressive disease for the individual patient. The forced expiratory volume in one second (FEV<sub>1</sub>) is declining with age as displayed in the Fletcher-Peto curve. Despite established benefits of bronchoscopic lung volume reduction (BLVR) using endobronchial valves (EBVs), long-term data suggest a gradual reduction in the magnitude of these benefits.PurposeThis study aimed to compare the rate of lung function change in emphysema patients undergoing BLVR versus those receiving conservative management, utilizing coarsened exact matching to ensure balanced baseline characteristics.Patients and MethodsIn this retrospective single center study data between 2015 and 2021 was analyzed. BLVR patients achieving significant volume reduction (≥563 mL) were matched to conservatively managed controls based on age, sex, BMI, and smoking history. Pulmonary function changes after successful BLVR with valves, including forced expiratory volume in one second (FEV<sub>1</sub>) and residual volume (RV), were monitored and analyzed over a 3-year period.ResultsA total of 60 patients, evenly distributed between the two groups (30 each), were included in the analysis. Median FEV<sub>1</sub> change was -0.063 L/year for BLVR patients and -0.066 L/year for controls. No statistically significant differences in annual FEV<sub>1</sub> and RV changes were observed (-0.07 vs -0.08, <i>p</i> = 0.492; -0.07 vs -0.07, <i>p</i> = 0.569; -0.05 vs -0.04, <i>p</i> = 0.636 at follow-ups in years 1, 2, and 3, respectively for FEV<sub>1</sub> and +0.20 vs +0.25, <i>p</i> = 0.643; +0.80 vs +0.65, <i>p</i> = 0.960; +1.0 vs +0.85, <i>p</i> = 0.963 at follow-ups in years 1, 2, and 3, respectively for RV).ConclusionIn this matched cohort analysis, no significant differences in annual changes in FEV<sub>1</sub> or RV progression were observed between patients after successful BLVR with valves and patients under conservative treatment. The results indicate that COPD progression is the main factor for the decline in functional improvement after successful BLVR with valves.</p>","PeriodicalId":10217,"journal":{"name":"Chronic Respiratory Disease","volume":"22 ","pages":"14799731251350709"},"PeriodicalIF":3.5000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12163258/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Chronic Respiratory Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/14799731251350709","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/11 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundChronic obstructive pulmonary disease (COPD) and emphysema display a chronic and progressive disease for the individual patient. The forced expiratory volume in one second (FEV1) is declining with age as displayed in the Fletcher-Peto curve. Despite established benefits of bronchoscopic lung volume reduction (BLVR) using endobronchial valves (EBVs), long-term data suggest a gradual reduction in the magnitude of these benefits.PurposeThis study aimed to compare the rate of lung function change in emphysema patients undergoing BLVR versus those receiving conservative management, utilizing coarsened exact matching to ensure balanced baseline characteristics.Patients and MethodsIn this retrospective single center study data between 2015 and 2021 was analyzed. BLVR patients achieving significant volume reduction (≥563 mL) were matched to conservatively managed controls based on age, sex, BMI, and smoking history. Pulmonary function changes after successful BLVR with valves, including forced expiratory volume in one second (FEV1) and residual volume (RV), were monitored and analyzed over a 3-year period.ResultsA total of 60 patients, evenly distributed between the two groups (30 each), were included in the analysis. Median FEV1 change was -0.063 L/year for BLVR patients and -0.066 L/year for controls. No statistically significant differences in annual FEV1 and RV changes were observed (-0.07 vs -0.08, p = 0.492; -0.07 vs -0.07, p = 0.569; -0.05 vs -0.04, p = 0.636 at follow-ups in years 1, 2, and 3, respectively for FEV1 and +0.20 vs +0.25, p = 0.643; +0.80 vs +0.65, p = 0.960; +1.0 vs +0.85, p = 0.963 at follow-ups in years 1, 2, and 3, respectively for RV).ConclusionIn this matched cohort analysis, no significant differences in annual changes in FEV1 or RV progression were observed between patients after successful BLVR with valves and patients under conservative treatment. The results indicate that COPD progression is the main factor for the decline in functional improvement after successful BLVR with valves.
背景:慢性阻塞性肺疾病(COPD)和肺气肿对个体患者来说是一种慢性和进行性疾病。Fletcher-Peto曲线显示,1秒用力呼气量(FEV1)随年龄的增长而下降。尽管使用支气管内瓣膜(ebv)进行支气管镜下肺减容(BLVR)有既定的益处,但长期数据表明这些益处的程度逐渐降低。目的本研究旨在比较肺气肿患者接受BLVR与接受保守治疗的肺功能变化率,利用粗精确匹配来确保平衡基线特征。患者和方法本回顾性单中心研究分析2015 - 2021年的数据。容积显著减少(≥563 mL)的BLVR患者与基于年龄、性别、BMI和吸烟史的保守管理对照组相匹配。在3年的时间里,监测和分析使用瓣膜进行BLVR成功后的肺功能变化,包括1秒用力呼气量(FEV1)和残余容积(RV)。结果共纳入60例患者,平均分布于两组(每组30例)。BLVR患者的平均FEV1变化为-0.063 L/年,对照组为-0.066 L/年。两组FEV1和RV的年变化差异无统计学意义(-0.07 vs -0.08, p = 0.492;-0.07 vs -0.07, p = 0.569;第1、2、3年随访时,FEV1和+0.20 vs +0.25分别为-0.05 vs -0.04, p = 0.636, p = 0.643;+0.80 vs +0.65, p = 0.960;+1.0 vs +0.85, p = 0.963分别在第1年、第2年和第3年随访RV)。结论在这项匹配的队列分析中,在瓣膜BLVR成功患者和保守治疗患者之间,FEV1或RV进展的年度变化无显著差异。结果表明,慢性阻塞性肺病的进展是瓣膜BLVR成功后功能改善下降的主要因素。
期刊介绍:
Chronic Respiratory Disease is a peer-reviewed, open access, scholarly journal, created in response to the rising incidence of chronic respiratory diseases worldwide. It publishes high quality research papers and original articles that have immediate relevance to clinical practice and its multi-disciplinary perspective reflects the nature of modern treatment. The journal provides a high quality, multi-disciplinary focus for the publication of original papers, reviews and commentary in the broad area of chronic respiratory disease, particularly its treatment and management.